-transparent.png){kind=logo}
3 aplastic patients with acute leukaemia, strongly HLA-immunized and refractory to platelet transfusions, received polyvalent gammaglobulin i.v. infusions (0.4 g/kg/d for 5 or 6 d) in association with daily random platelet transfusions. Platelet recovery was obtained in 2 patients. The 3rd patient did not show any significant rise in platelet count. The ability of gammaglobulin to prolong the life-span of incompatible transfused platelets could facilitate the management of HLA-immunized patients.
Related Publications
P Bierling, and
C Cordonnier, and
M Rodet, and
J P Vernant, and
A Pesce, and
H Rochant, and
N Duedari
October 1984,
Blood,
P Bierling, and
C Cordonnier, and
M Rodet, and
J P Vernant, and
A Pesce, and
H Rochant, and
N Duedari
February 1986,
Scandinavian journal of haematology,
P Bierling, and
C Cordonnier, and
M Rodet, and
J P Vernant, and
A Pesce, and
H Rochant, and
N Duedari
April 1985,
Lancet (London, England),
P Bierling, and
C Cordonnier, and
M Rodet, and
J P Vernant, and
A Pesce, and
H Rochant, and
N Duedari
January 1988,
British medical journal (Clinical research ed.),
P Bierling, and
C Cordonnier, and
M Rodet, and
J P Vernant, and
A Pesce, and
H Rochant, and
N Duedari
January 1989,
Metabolic, pediatric, and systemic ophthalmology (New York, N.Y. : 1985),
P Bierling, and
C Cordonnier, and
M Rodet, and
J P Vernant, and
A Pesce, and
H Rochant, and
N Duedari
April 1984,
Lancet (London, England),
P Bierling, and
C Cordonnier, and
M Rodet, and
J P Vernant, and
A Pesce, and
H Rochant, and
N Duedari
November 1984,
Lancet (London, England),
P Bierling, and
C Cordonnier, and
M Rodet, and
J P Vernant, and
A Pesce, and
H Rochant, and
N Duedari
February 1984,
Lancet (London, England),
P Bierling, and
C Cordonnier, and
M Rodet, and
J P Vernant, and
A Pesce, and
H Rochant, and
N Duedari
December 1983,
Lancet (London, England),
P Bierling, and
C Cordonnier, and
M Rodet, and
J P Vernant, and
A Pesce, and
H Rochant, and
N Duedari
February 1985,
Lancet (London, England),
